e-learning
resources
Amsterdam 2015
Wednesday, 30.09.2015
Cellular and molecular mechanisms of COPD and emphysema
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Receptor for advanced glycation end products (RAGE) is involved in cigarette smoke induced inflammation and emphysema
Lisa Wolf (Homburg/Saar, Germany), Lisa Wolf, Julia Niederstraßer, Herr Christian, Bals Robert
Source:
International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Session:
Cellular and molecular mechanisms of COPD and emphysema
Session type:
Poster Discussion
Number:
5048
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Lisa Wolf (Homburg/Saar, Germany), Lisa Wolf, Julia Niederstraßer, Herr Christian, Bals Robert. Receptor for advanced glycation end products (RAGE) is involved in cigarette smoke induced inflammation and emphysema. Eur Respir J 2015; 46: Suppl. 59, 5048
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Therapeutic neutralization of the matrikine PGP suppresses the development of lung emphysema in cigarette smoke exposed mice
Source: International Congress 2016 – Mechanisms of disease
Year: 2016
Advanced glycation end product (AGE), soluble receptor for AGE (sRAGE) and inflammation in smokers and mild/moderate chronic obstructive pulmonary disease (COPD)
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
Ceramide-1-phosphate attenuates cigarette smoke induce lung inflammation
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013
Implication of interleukin-10 in the development of COPD induced by cigarette smoke exposure in mice
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Comparison of the effects of e-cigarette vapor vs cigarette smoke on lung function and inflammation in mice
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015
Cigarette smoke-induced lung inflammation is skewed in estrogen receptor-alpha deficient mice
Source: Annual Congress 2013 –The role of hormones and cytokines in lung injury
Year: 2013
Signalling through the receptor for advanced glycation end products (RAGE) is increased in acute asthma and correlates with symptom severity
Source: International Congress 2016 – What's new in biomarker analysis?
Year: 2016
Cryptotanshinone attenuates airway Inflammation induced by cigarette smoke in mice
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Cigarette smoke activates ER overload response in Z-AT mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
High fructose intake increases alveolar enlargement and muscle inflammation in mice exposed to cigarette smoke
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Inhibition of lung inflammation by a protein epitope mimetic (PEM) neutrophil elastase inhibitor, POL6014, in a sub-chronic tobacco smoke (TS) model in mice
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013
Eucalyptol reduced inflammation and oxidative stress on mouse lungs exposed to long and short-term cigarette smoke
Source: International Congress 2015 – Inflammation and remodelling in lung disease
Year: 2015
Increased expression of receptor for advanced glycation end products in COPD
Source: International Congress 2014 – Translational studies in COPD
Year: 2014
Chronic treatment of beta-blocker inhibited mucus hypersecretion and MUC5AC expression exposed to cigarette smoking through beta-arrestin2–ERK1/2 pathway
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Cytokine and chemokine expression in cigarette smoke-induced lung injury in guinea pigs
Source: Eur Respir J 2005; 26: 993-1001
Year: 2005
An experimental model of elastase and cigarette smoke- induced emphysema in mice
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
RAGE and cigarette smoke-induced pulmonary lesions: a chronic study on genetically manipulated mice
Source: Annual Congress 2009 - From emphysema to fibrosis: mechanisms of cellular remodelling in the diseased lung
Year: 2009
Interleukin-17A/F regulates MMP-9 expression in the lung of mice after inhalation of cigarette smoke
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
cPLA2alpha plays a role in neutrophilic inflammatory response in mice induced by tobacco smoke exposure
Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept